Babajide, O.
, Kjaergaard, A. D., Deng, W., Kuś, A., Sterenborg, R. B. T. M., Åsvold, B. O., Burgess, S., Teumer, A., Medici, M., Ellervik, C., Nick, B., Deloukas, P. & Marouli, E. (2024).
The role of thyroid function in borderline personality disorder and schizophrenia: a Mendelian Randomisation study.
Borderline Personality Disorder and Emotion Dysregulation,
11, Article 2.
https://doi.org/10.1186/s40479-024-00246-3
Billing, A. M., Kim, Y. C.
, Gullaksen, S., Schrage, B., Raabe, J., Hutzfeldt, A.
, Demir, F., Kovalenko, E., Lassé, M., Dugourd, A., Fallegger, R., Klampe, B., Jaegers, J.
, Li, Q., Kravtsova, O., Crespo-Masip, M., Palermo, A.
, Fenton, R. A., Hoxha, E.
... Rinschen, M. M. (2024).
Metabolic Communication by SGLT2 Inhibition.
Circulation,
149(11), 860-884.
https://doi.org/10.1161/CIRCULATIONAHA.123.065517
Carramolino, L.
, Albarrán-Juárez, J., Markov, A., Hernández-SanMiguel, E.
, Sharysh, D., Cumbicus, V., Morales-Cano, D., Labrador-Cantarero, V.
, Møller, P. L., Nogales, P., Benguria, A., Dopazo, A., Sanchez-Cabo, F., Torroja, C.
& Bentzon, J. F. (2024).
Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes.
Nature Cardiovascular Research,
3(2), 203-220.
https://doi.org/10.1038/s44161-023-00412-w